ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · IEX Real-Time Price · USD
10.53
-0.01 (-0.09%)
Jul 22, 2024, 10:30 AM EDT - Market open
ARS Pharmaceuticals Employees
As of December 31, 2023, ARS Pharmaceuticals had 26 total employees, including 24 full-time and 2 part-time employees. The number of employees increased by 6 or 30.00% compared to the previous year.
Employees
26
Change (1Y)
6
Growth (1Y)
30.00%
Revenue / Employee
$385
Profits / Employee
-$1,911,385
Market Cap
1.02B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 26 | 6 | 30.00% |
| Dec 31, 2022 | 20 | 11 | 122.22% |
| Dec 31, 2021 | 9 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| OPKO Health | 3,930 |
| Avanos Medical | 3,771 |
| BioLife Solutions | 414 |
| Tarsus Pharmaceuticals | 244 |
| Calliditas Therapeutics AB (publ) | 217 |
| Tango Therapeutics | 140 |
| Pharvaris | 82 |
| Pulse Biosciences | 56 |
SPRY News
- 2 days ago - ARS Pharmaceuticals Inc Is Under Investigation By The Schall Law Firm And Impacted Investors Are Encouraged To Initiate Dialogues - Accesswire
- 3 days ago - The Schall Law Firm Is Investigating ARS Pharmaceuticals Inc And Urges Affected Investors To Start Conversations - Accesswire
- 4 days ago - ARS Pharmaceuticals Inc Is Under Examination By The Schall Law Firm, Impacted Investors Are Encouraged To Initiate Dialogues - Accesswire
- 5 days ago - The Schall Law Firm Urges Affected Investors To Start Conversation, ARS Pharmaceuticals Inc Is Under Scrutiny - Accesswire
- 6 days ago - ARS Pharmaceuticals Inc Under Investigation By The Schall Law Firm Encouraging Impacted Investors To Initiate Dialogue - Accesswire
- 8 days ago - The Schall Law Firm Begins Probe Into ARS Pharmaceuticals Inc And Urges Affected Investors To Start Conversation - Accesswire
- 9 days ago - Investigation Into ARS Pharmaceuticals Inc Initiated By The Schall Law Firm Encouraging Impacted Investors To Begin Dialogue - Accesswire
- 10 days ago - ARS Pharmaceuticals Inc Under Investigation By The Schall Law Firm Urging Affected Investors To Initiate Conversation - Accesswire